Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDrax Regulatory News (DRX)

Share Price Information for Drax (DRX)

Share Price is delayed by 15 minutes
Get Live Data
780.00    -4.50 (-0.57%)
Bid:
780.50
Ask:
781.50
Spread: 1.00 (0.128%)
Market Cap: £2.62b
DRX Live PriceLast checked at - London Stock Exchange

Intraday Drax Share Chart

Share Buyback Programme

28 Feb 2025 07:00

RNS Number : 7901Y
Drax Group PLC
28 February 2025
 

28 February 2025

 

DRAX GROUP PLC

(Symbol: DRX)

 

Share Buyback Programme

 

On 22 October 2024, Drax Group plc (the "Company") announced that in connection with the up to £300 million share buyback programme announced on 26 July 2024 to purchase ordinary shares of 11 16/29 pence each in the Company (the "Programme"), it was commencing the second tranche of the Programme up to a maximum consideration of £75 million (the "Second Tranche"). As at 27 February 2025, the Company had repurchased a total of 23,369,775 shares for a consideration of c.£150 million in aggregate across the First and Second Tranche.

 

The Company is today confirming that the third tranche of the Programme to purchase ordinary shares in the Company up to a maximum consideration of £75 million (the "Third Tranche") is expected to commence on the conclusion of the Second Tranche.

 

The purpose of the Third Tranche is to reduce the Company's share capital. The ordinary shares purchased by the Company will be held in treasury pending cancellation or re-issue.

 

Ordinary share purchases as part of the Third Tranche will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volumes. The maximum number of shares that may be repurchased by the Company under the remainder of the Second Tranche and Third Tranche of the Programme is 15,098,482 being the number of shares the Company is authorised to purchase pursuant to the authority granted by shareholders at the AGM on 25 April 2024 less the shares acquired under the First and Second Tranches. The Company expects the required authority will be renewed at the AGM to be held on 1 May 2025.

 

The Company has entered into a non-discretionary agreement with RBC Europe Limited ("RBC") pursuant to which it has issued irrevocable instructions to RBC to conduct the Third Tranche of the Programme. RBC will carry out the Third Tranche of the Programme through the acquisition of ordinary shares in the Company within certain pre-defined parameters for subsequent repurchase by the Company. Any purchase of ordinary shares in the Company will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014 and the Commission Delegated Regulation (EU) 2016/1052 (also as in force in the UK, from time to time, including, where relevant, pursuant to the UK's European Union (Withdrawal) Act 2018 and the Market Abuse (Amendment) (EU Exit) Regulations 2019) as well as applicable laws and the regulations of the UK Financial Conduct Authority (including Chapter 9 of the UK Listing Rules).

 

The Company will make further announcements in due course following the buyback of shares. Note there is no guarantee that the Programme will be implemented in full.

 

Capitalised terms relate to the Company's announcements on 7 August 2024 and 22 October 2024 unless specified otherwise.

 

Enquiries:

Drax Investor Relations: Mark Strafford

+44 (0) 7730 763 949

 

Media:

Drax External Communications: Andy Low

+44 (0) 7841 068 415 

 

RBC Europe Limited:

James Agnew / Jack Wood

+44 (0) 20 7404 5959

 

Website: www.drax.com

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMZGZZRNKGKZM
Date   Source Headline
20th Nov 20246:10 pmRNSTransaction in Own Shares
19th Nov 20245:51 pmRNSTransaction in Own Shares
18th Nov 20245:55 pmRNSTransaction in Own Shares
15th Nov 20245:45 pmRNSTransaction in Own Shares
14th Nov 20245:39 pmRNSTransaction in Own Shares
13th Nov 20246:20 pmRNSTransaction in Own Shares
12th Nov 20246:16 pmRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTrading Update
11th Nov 20245:39 pmRNSTransaction in Own Shares
8th Nov 20246:23 pmRNSTransaction in Own Shares
6th Nov 20245:53 pmRNSTransaction in Own Shares
5th Nov 20245:56 pmRNSTransaction in Own Shares
4th Nov 20245:42 pmRNSTransaction in Own Shares
4th Nov 202411:49 amRNSTotal Voting Rights
1st Nov 20245:34 pmRNSTransaction in Own Shares
31st Oct 20245:37 pmRNSTransaction in Own Shares
30th Oct 20245:31 pmRNSTransaction in Own Shares
29th Oct 20245:50 pmRNSTransaction in Own Shares
28th Oct 20245:28 pmRNSTransaction in Own Shares
25th Oct 20245:22 pmRNSTransaction in Own Shares
25th Oct 20247:00 amRNSTransaction in Own Shares
24th Oct 20247:00 amRNSTransaction in Own Shares
22nd Oct 20246:27 pmRNSTransaction in Own Shares
22nd Oct 20247:00 amRNSShare Buyback Programme
21st Oct 20245:50 pmRNSTransaction in Own Shares
21st Oct 20243:30 pmRNSDirector/PDMR Shareholding
18th Oct 20245:54 pmRNSTransaction in Own Shares
18th Oct 20247:00 amRNSTransaction in Own Shares
17th Oct 20247:00 amRNSTransaction in Own Shares
16th Oct 20247:00 amRNSTransaction in Own Shares
15th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 20246:20 pmRNSTransaction in Own Shares
10th Oct 20245:34 pmRNSTransaction in Own Shares
9th Oct 20245:43 pmRNSTransaction in Own Shares
8th Oct 20245:46 pmRNSTransaction in Own Shares
7th Oct 20245:43 pmRNSTransaction in Own Shares
7th Oct 20248:45 amRNSAdditional Listing
7th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20245:35 pmRNSTransaction in Own Shares
2nd Oct 20245:47 pmRNSTransaction in Own Shares
1st Oct 20246:12 pmRNSTransaction in Own Shares
1st Oct 202412:49 pmRNSNotice of Change to Director Details
1st Oct 20249:47 amRNSBlock listing Interim Review
1st Oct 20249:45 amRNSBlock listing Interim Review
1st Oct 20249:43 amRNSBlock listing Interim Review
1st Oct 20249:42 amRNSBlock listing Interim Review
1st Oct 20249:36 amRNSTotal Voting Rights
30th Sep 20245:40 pmRNSTransaction in Own Shares
27th Sep 20245:33 pmRNSTransaction in Own Shares
26th Sep 20245:51 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.